用于光化性角化病的甲基氨基乙酰丙酸光动力疗法不会影响外周调节性T细胞水平或功能。 - Suppr

Suppr

超能文献

Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.

作者信息

Reginato Eleonora, Gruber-Wackernagel Alexandra, Wolf Peter

机构信息

Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Graz, Austria.

出版信息

Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):274-8. doi: 10.1111/phpp.12178. Epub 2015 Apr 20.

DOI:10.1111/phpp.12178

PMID:25847118

Abstract

摘要

相似文献

Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.

Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):274-8. doi: 10.1111/phpp.12178. Epub 2015 Apr 20.

[Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].

Actas Dermosifiliogr. 2010 May;101(4):315-22.

Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer.

Actas Dermosifiliogr. 2015 Jan-Feb;106(1):70-1. doi: 10.1016/j.ad.2014.04.010. Epub 2014 Jul 31.

Ablative non-sequential fractional ultrapulsed CO laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model.

Exp Dermatol. 2016 Dec;25(12):997-999. doi: 10.1111/exd.13068. Epub 2016 Oct 3.

Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms.

G Ital Dermatol Venereol. 2019 Oct;154(5):603-605. doi: 10.23736/S0392-0488.18.05910-2. Epub 2018 Feb 26.

Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.

J Am Acad Dermatol. 2012 Dec;67(6):1386-7. doi: 10.1016/j.jaad.2012.05.039.

Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.

Acta Derm Venereol. 2016 Jun 15;96(5):712-3. doi: 10.2340/00015555-2345.

Photodynamic therapy for actinic keratoses: aren't we there yet?

JAMA Dermatol. 2014 Dec;150(12):1289. doi: 10.1001/jamadermatol.2014.1869.

Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.

Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):233-8. doi: 10.1111/phpp.12164. Epub 2015 Feb 19.

Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses.

Acta Derm Venereol. 2017 Jan 4;97(1):120-121. doi: 10.2340/00015555-2484.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.

作者信息

Reginato Eleonora, Gruber-Wackernagel Alexandra, Wolf Peter

机构信息

Research Unit for Photodermatology, Department of Dermatology, Medical University of Graz, Graz, Austria.

出版信息

Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):274-8. doi: 10.1111/phpp.12178. Epub 2015 Apr 20.

DOI:10.1111/phpp.12178

PMID:25847118

Abstract

摘要

相似文献

Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.

Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):274-8. doi: 10.1111/phpp.12178. Epub 2015 Apr 20.

[Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].

Actas Dermosifiliogr. 2010 May;101(4):315-22.

Malassezia growth on peritumoral skin after routine methyl-5-aminolevulinate photodynamic therapy for actinic keratosis and nonmelanoma skin cancer.

Actas Dermosifiliogr. 2015 Jan-Feb;106(1):70-1. doi: 10.1016/j.ad.2014.04.010. Epub 2014 Jul 31.

Ablative non-sequential fractional ultrapulsed CO laser pretreatment improves conventional photodynamic therapy with methyl aminolevulinate in a novel human in vitro 3D actinic keratosis skin model.

Exp Dermatol. 2016 Dec;25(12):997-999. doi: 10.1111/exd.13068. Epub 2016 Oct 3.

Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms.

G Ital Dermatol Venereol. 2019 Oct;154(5):603-605. doi: 10.23736/S0392-0488.18.05910-2. Epub 2018 Feb 26.

Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.

J Am Acad Dermatol. 2012 Dec;67(6):1386-7. doi: 10.1016/j.jaad.2012.05.039.

Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.

Acta Derm Venereol. 2016 Jun 15;96(5):712-3. doi: 10.2340/00015555-2345.

Photodynamic therapy for actinic keratoses: aren't we there yet?

JAMA Dermatol. 2014 Dec;150(12):1289. doi: 10.1001/jamadermatol.2014.1869.

Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.

Photodermatol Photoimmunol Photomed. 2015 Sep;31(5):233-8. doi: 10.1111/phpp.12164. Epub 2015 Feb 19.

Long-term Outcome of Low-concentration Hexyl-5-aminolaevulinate Daylight Photodynamic Therapy for Treatment of Actinic Keratoses.

Acta Derm Venereol. 2017 Jan 4;97(1):120-121. doi: 10.2340/00015555-2484.